Influence of spironolactone and dexamethasone on phosphoprotein phosphatase in the rat liver, kidney and spleen.
D000818:Animals; D002364:Caseins; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008861:Microsomes / Q000201:enzymology; D010750:Phosphoproteins; D010744:Phosphoric Monoester Hydrolases / Q000096:biosynthesis / Q000378:metabolism*; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D013148:Spironolactone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013154:Spleen / Q000187:drug effects / Q000201:enzymology
D002364:Caseins; D010750:Phosphoproteins; D003609:Dactinomycin; D013148:Spironolactone; D003907:Dexamethasone; D003513:Cycloheximide; D011335:Proadifen; D010744:Phosphoric Monoester Hydrolases